Information on New Approvals and Medication Safety
Search results for: musculoskeletal disease
Meet the Model Biologics Policy
At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
Rheumatology and the Patient-Centered Home
Is it the end of the tunnel or an oncoming train?
The ACR Benchmark Survey Results
In 2009, the ACR’s Committee on Rheumatologic Care (CORC) began its third Economic Benchmark Survey to update information from the previous surveys conducted in 1999 and 2003.
When Lupus Research is a Family Affair
Following sisters of SLE patients may shed light on risk factors and progression of the disease
In Advocacy, Slow and Steady Wins the Race
Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.
The Law of Unintended Consequences Rears Its Head
A program to improve drug safety has increased drug prices for patients with gout and FMF
Global Insights from the Bone and Joint Decade Network Conference
Global insights from the Bone and Joint Decade Network Conference
Sex Differences & Rheumatoid Arthritis
The beliefs versus the data
The Health Buzz
What is the ACR doing with healthcare reform?
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 94
- Next Page »